Wordt geladen...
Monoclonal antibodies as disease modifying therapy in multiple sclerosis
Multiple sclerosis (MS), a demyelinating disease of the central nervous system, was untreatable until the mid-1990s when beta-interferons and glatiramer acetate were introduced. These agents, while effective, were relatively nonspecific in action. Over the last 10 years, research has focused towards...
Bewaard in:
| Hoofdauteurs: | , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2013
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3967547/ https://ncbi.nlm.nih.gov/pubmed/24027005 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11910-013-0390-z |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|